Vancomycin-resistant enterococci

Annals of Pharmacotherapy

Volumn 30, Issue 6, 1996, Pages 615-624

  Gin, Alfred S ^a,b   Zhanel, George G ^b,c,d  

^a HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Division of Clinical Sciences

^d Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DEPSIPEPTIDE; GENTAMICIN; GLYCOPEPTIDE; NETILMICIN; NITROCEFIN; NITROFURANTOIN; NOVOBIOCIN; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PENICILLIN G; PEPTIDOGLYCAN; RAMOPLANIN; STREPTOMYCIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD CULTURE; DRUG BINDING; EDUCATION; ENTEROCOCCUS FAECALIS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PENICILLIN ALLERGY; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STREPTOCOCCUS INFECTION;

EID: 0029929795     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000610     Document Type: Article

References (82)

1. Tailor SAN, Bailey EM, Rybak MI. Enterococcus, an emerging pathogen. Ann Pharmacother 1993;27:1231-42.
2. Murray BE. The life and limes of the Enterococcus. Clin Microbiol Rev 1990;3:46-65.
3. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
4. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
5. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
6. Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep 1995;44(RR-12):1-19.
7. Feldman RJ, Paul S, Cody R, Noveck H, Silber JL, Weinstein MR Analysis of treatment for patients with vancomycin-resistant enterococcal bacteremia (abstract). 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL, October 5, 1994.
8. Bates J, Gardenias Z, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994;34:507-14.
9. Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F. vanA-mediated vancomycin-resistanl Enterococcus spp. in sewage. J Antimicrob Chemother 1994;33:553-61.
10. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
11. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;93:195-8.
12. Green M, Wadowsky RM, Barabadora K. Recovery of vancomycin-resistant gram-positive cocci from children. J Clin Microbiol 1990;28:484-8.
13. Green M, Barabadora K, Michaels M. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 1991;29:2503-6.
14. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990;3:280-91.
15. Performance standards for antimicrobial disk susceptibility tests. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
16. Toala P, McDonald A, Wilcox C, Finland M. Susceptibility of group D Streptococcus (Enterococcus) to 21 antibiotics in vitro with special reference to species differences. Am J Med Sci 1969;258:416-30.
17. Harwick HJ, Kalmanson GM, Guze LB. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob Agents Chemother 1973;4:383-7.
18. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-81.
19. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
20. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989;33:10-5.
21. Shlaes DM, Bouvet A, Devine C, Shlaes JH, Al-Obeid S, Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother 1989;33:198-203.
22. Williamson R, Al-Obeid S, Shlaes JH, Goldstein FW, Shlaes DM. Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis 1989;159:1095-104.
23. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989;33;1588-91.
24. Shlaes DM, Al-Obeid S, Shlaes JH, Boisivon A, Williamson R. Inducible, transferable resistance to vancomycin Enterococcus faecium, D399. J Antimicrob Chemother 1989;23:503-8.
25. Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P, Cezard JP, Navarro J. Bacteremia caused by a vancomycin-resistant Enterococcus. Pediatr Infect Dis J 1989;8:475-6.
26. Peetermans WE, Sebens FW, Guiot HFL. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991;23:105-9.
27. Pouedras P, Leclercq R, Donnio PY, Sire JM, Mesnard R, Avril JL. Bacteremia due to a vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin. Clin Infect Dis 1992; 15:752-3.
28. Venditti M, Viavasco B, Varaldo PE, Macchiarelli A, De Biase L, Marino B, et al. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart. Clin Infect Dis 1993;17: 524-5.
29. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992;14:655-61.
30. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly re- sistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16:750-5.
31. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
32. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32:1148-53.
33. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:5515-28.
34. Edmond MB, Ober JF, Weinbaum DL, Pfaher MA, Hwang T, Sandford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
35. McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J Clin Microbiol 1994;32:2671-6.
36. Murray BE. What can we do about vancomycin-resistant enterococci? Clin Infect Dis 1995;20:1134-6.
37. Rhinehart E, Smith ME, Wennersten C, Gorss E, Freeman J, Eliopoulos GM, et al. Rapid dissemination of beta-lactamase-producing aminoglycoside-resistant Enterococcus faecium among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:1814-8.
38. Guiot HFL, Peeterman WE, Sehens FW. Isolation of vancomycin-resistant enterococci in haematologic patients. Eur J Clin Microbiol Infect Dis 1991;10:32-4.
39. Chadwick PR, Oppenheim BA. Vancomycin-resistant enterococci and bedpan washer machines (letter). Lancet 1994;344:685.
40. Livomese LL, Dias S, Samel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117: 112-6.
41. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
42. Schulz JE, Sahm DF. Reliability of the E-test for detection of ampicillin, vancomycin and high level aminoglycoside resistance in Enterococcus spp. J Clin Microbiol 1993;31:3336-9.
43. Sahm DF, Torres C. Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis. J Clin Microbiol 1988;26:250-6.
44. Fontana R, Bertoloni G, Amalfitano G, Canepari P. Characterization of penicillin-resistant Streptococcus faecium mutants. FEMS Microbiol Lett 1984;25:21-5.
45. Williamson R, Calderwcod SB, Moellering RC, Tomasz A. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci. J Gen Microbiol 1983;129:813-22.
46. Fontana R, Grossato A, Rossi L, Cheng YR, Satta G. Transition from resistance to hypersusceptibility to β-lactam antibiotics associated with the loss of a low-affinity penicillin binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother 1985;28:678-83.
47. Murray BE. β-Lactamase producing enlerococci. Antimicrob Agents Chemother 1992;36:2355-9.
48. Herman DJ, Gerding DN. Screening and treatment of infections caused by resistant enterococci. Antimicrob Agent Chemother 1991;35:215-9.
49. 14C-labelled streptomycin by enterococci. J Clin Invest 1971;50:2580-4.
50. Barna JC, Williams DH. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol 1984;38: 339-57.
51. Reynolds PE. Glycopeptide resistance in gram-positive bacteria. J Med Microbiol 1992;36:4-29.
52. Nagarajan R. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrob Agents Chemother 1991;35:605-9.
53. Courvalin P. Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother 1990;34:2291-6.
54. Dutka-Malen S, Courvalin P. Update of glycopeptide resistance in enterococci. Antimicrob Newsl 1990;7:81-6.
55. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993;37:1563-71.
56. Leclercq R, Dutka-Malen S, Brisson-Noel A, Molinas C, Derlot E, Arthur M, et al. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 1992;15:495-501.
57. Hayden MK, Trenholme GM, Schultz JE, Sahm DF. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis 1993;167:1224-7.
58. Evers S, Sahm DF, Courvalin P. The vanB gene of vancomycin resistant Entemcoccus faecalis V583 is structurally related to genes encoding D-Ala:o-Ala ligases and glycopeptide resistance proteins VanA and VanC. Gene 1993;24:143-4.
59. Quintiliani R, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 1993;167:1220-3.
60. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546: a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175:117-27.
61. Al-Obeid S, Gutmann L, Shlaes DM, Williamson R, Collatz E. Comparison of vancomycin-inducible proteins from four strains of enterococci. FEMS Microbiol Lett 1990;70:101-6.
62. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. The VanA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet 1990;224:264-72.
63. Misan GMH, Martin ED, Smith ER, Somogyi AA, Bartholomeusz RC, Bochner F. Drug utilization review in a teaching hospital: experience with vancomycin. Eur J Clin Pharmacol 1990;39:457-61.
64. Nightingale J, Chaffee BW, Colvin CL, Alexander MR, Rice T, Ross MB. Retrospective evaluation of vancomycin use in a university hospital. Am J Hosp Pharm 1987;44:1807-9.
65. Lin A, Flint N, Johnson M, Ostrosky J, Kirkwood C, Healy D. Criteria for use of intravenous vancomycin for treatment of infections. Clin Pharm 1990;9:718-22.
66. Kerr JR. Penicillin/allergy: a study of incidence as reported by patients. Br J Clin Pract 1994;1:5-7.
67. Kelly CP, Pothoulakis C, LaMont LJ. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
68. Westenfelder GO, Paterson PY, Reisberg BE, Carlson GM. Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA 1973; 223:37-40.
69. Ikeda DP, Barry AL, Andersen SG. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides. Diagn Microbiol Infect Dis 1984;2:171-7.
70. Eliopoulos GM, Willey G, Murray BE, Moellering RC. Ciprofloxacin in experimental endocarditis due to a beta-lactamase producing highly gentamicin-resistant strain of E. faecalis. Rev Infect Dis 1989;11(suppl 5): 1210-1.
71. Thauvin C, Eliopoulos GM, Willey S, Wennesten C, Moellering RC. Continuous infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother 1987;31:139-43.
72. Mobarakai N, Quale JM, Landman D. Bactericidal activities of peptide antibiotics against multidrug resistant Enterococcus faecium. Antimicrob Agents Chemolher 1994;38:385-7.
73. Gutmann L, Al-Obeid S, Billot-Klein D, Guerrier ML, Collatz E. Synergy and resistance to synergy between β-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. Antimicrob Agents Chemother 1994;38:824-9.
74. Hayden MK, Koenig GI, Trenholme GM. Bactericidal activities of antibiotics against vancomycin resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrob Agents Chemother 1994;38:1225-9.
75. Collins LA, Eliopoulos GM, Wennesten CB, Ferraro MJ, Moellering RC. In vitro activity of ramoplanin against vancomycin resistant grampositive organisms. Antimicrob Agents Chemother 1993;37:1364-6.
76. Caron F, Carbon C, Gutmann L. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1994;164:888-93.
77. Caron F, Pestel M, Kitzis MD, Lemeland JI, Humbert G, Gutmann L. Comparison of different β-lactam glycopeptide gentamicin combinations for an experimental endocarditis caused by a highly β-lactam resistant and highly glycopeptide resistant isolate of Enterococcus faecium. J Infect Dis 1995;171:106-12.
78. French P, Venuti E, Frainow HS. In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium. Antimicrob Agents Chemother 1993;37:2736-9.
79. Whitman MS, Pitsaakis PG, Zausner A, Livornese LL, Osborne AJ, Johnson CC, et al. Antibiotic treatment of experimental endocarditis due to vancomycin and ampicillm-resistant Enterococcus faecium. Antimicrob Agents Chemother 1993;37:2069-73.
80. Landman D, Mobarakai NK, Quale JM. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin and gentamicin. Antimicrob Agents Chemother 1993;37:1904-8.
81. Willey BM, Degani D, McGeer A. Comparative in vitro activities of new agents against Canadian enterococcal isolates (abstract). Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 5, 1994.
82. Morris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20:1137-44.